Is Ketamine Therapy Safe? What 30,000+ Sessions Taught Us

With ketamine back in the news after the Matthew Perry case, more people are asking whether therapeutic ketamine is safe. The short answer: clinical ketamine therapy under medical supervision is fundamentally different from illicit use. Here's what our Harvard-trained psychiatrists want you to know.

As ketamine therapy becomes more widely available for conditions like depression, anxiety, and PTSD, a natural and vital question emerges for many patients: Is ketamine therapy safe?

This isn’t just a medical question — it’s a personal one. Safety is the foundation of trust in any therapeutic relationship. And for individuals considering a treatment as powerful as ketamine, understanding its risks and benefits is essential.

In this post, we’ll explore ketamine’s safety through multiple lenses: its pharmacological history, modern clinical use, dosage protocols, and the safety considerations that guide responsible care. Our goal at Lumin Health is to answer not just “Is ketamine safe?” but also: Under what conditions is it safest? and How can we help patients feel protected and empowered throughout the process?

Ketamine Therapy: A Longstanding Medical Legacy

To understand how safe is ketamine, it helps to start with its history. Ketamine was developed in the 1960s as a safer alternative to other anesthetics. Since then, it has been used for decades in emergency rooms, operating rooms, and even battlefield medicine.

Why? Because ketamine's safety profile is exceptional when compared to many anesthetic agents. It does not depress respiration in the way opioids or benzodiazepines do, making it particularly valuable in acute care.^[6]

This long medical track record supports the foundational claim that, yes, ketamine is safe — especially when administered by trained professionals within appropriate settings.

Is Ketamine Therapy Safe for Mental Health Conditions?

But is ketamine therapy safe when used for psychiatric conditions?

This is where nuance matters. In mental health, ketamine therapy is typically given in much lower doses than in surgical settings. These “subanesthetic” doses are not designed to render someone unconscious, but to shift perception and support therapeutic change.

In carefully controlled environments — such as the clinics at Lumin Health — these lower doses are well tolerated by the vast majority of patients. Monitoring protocols are in place to track vital signs, manage side effects, and ensure emotional containment during and after sessions.

Numerous clinical trials have confirmed that ketamine therapy is safe for patients with treatment-resistant depression when delivered in this way.^[1,2] Adverse events are rare, and most side effects (such as mild nausea, dizziness, or temporary dissociation) resolve quickly with supportive care.

Understanding the Ketamine Safety Profile

Every medication has a safety profile — a detailed map of its effects, risks, and contraindications. Ketamine’s safety profile, fortunately, is robust.

Here’s what we know:

• Cardiovascular effects: Ketamine can cause a temporary increase in heart rate and blood pressure. For most patients, this is mild and well-tolerated.^[4] Patients with uncontrolled hypertension or certain cardiac conditions may need extra screening or precautions.
• Neurological effects: Ketamine can cause temporary dissociation, perceptual changes, or dreamlike states. These effects are not dangerous, but they can be unsettling if not properly prepared for. Integration support helps patients process and contextualize these experiences.
• Addiction risk: While ketamine does have abuse potential in recreational contexts, the structured use of ketamine in therapy — with measured dosing and clinical oversight — carries a low risk of dependence.^[5] Patients are screened for substance use history, and ongoing monitoring helps mitigate any risk.
• Cognitive safety: Some patients worry that ketamine might impair memory or thinking. The research to date suggests that in controlled, therapeutic doses, ketamine does not lead to long-term cognitive decline.^[2] On the contrary, it may help restore cognitive flexibility in those with depression.

In short, the ketamine safety profile is favorable — but it must be respected. The key is not whether ketamine is safe in the abstract, but whether it is used wisely, ethically, and with appropriate safeguards in place.

The Ketamine Safe Dose Range

One of the cornerstones of safe ketamine therapy is dosing. The ketamine safe dose range for psychiatric use is significantly lower than for surgical anesthesia, but each person is different and dosage will be carefully considered in partnership with your provider. Here’s a simplified breakdown:

• IV infusion: Typically 0.5 mg/kg over 40 minutes for depression
• Intramuscular (IM) injection: Often starts around 0.7–1.0 mg/kg
• Intranasal (Spravato/esketamine): Administered in fixed doses (56–84 mg) under FDA guidance
• Oral lozenges: Ranges from 100–300 mg depending on absorption and tolerance

Clinicians begin at the low end of the ketamine safe dose range, then titrate upward based on patient response. The aim is to induce a therapeutic state without overwhelming the system. Most patients can expect a temporary dissociative experience — an altered state of awareness that may feel unfamiliar but is medically safe when supported in the right setting.

This precision matters. Safety doesn’t come from the medicine alone — it comes from the thoughtful calibration of dose, timing, and context.

Patient-Centered Precautions

For those still asking, “Is ketamine safe?”, it’s important to emphasize that true safety is more than physical protection. It’s about emotional containment, psychological preparation, and personalized care.

At Lumin Health, we take several steps to ensure that each patient feels safe throughout the therapeutic arc:

• Thorough screening for physical and psychiatric contraindications
• Careful dosing based on body weight, medical history, and previous responses
• Supervised administration with licensed clinicians present throughout the session
• Recovery monitoring for at least 1–2 hours post-treatment
• Integration support through therapy or guided reflection to process what emerges

These measures help make ketamine therapy safe not just in theory, but in practice.

Risks of Ketamine Therapy in Context

No treatment is without risk. But the risks associated with ketamine — when delivered responsibly — are generally low and manageable. For comparison, consider that traditional antidepressants may take weeks to work and often carry side effects like sexual dysfunction, weight gain, or emotional numbing. Ketamine offers an alternative that works quickly, with a different side effect profile — and for many, greater efficacy.

The question how safe is ketamine is not about eliminating all uncertainty. It’s about making a well-informed, collaborative decision based on clinical evidence and personal readiness.

So, Is Ketamine Therapy Safe? 

Yes — when it is done with care, clarity, and clinical oversight. Its safety profile is among the most favorable in psychiatric medicine, especially when used at therapeutic doses within a structured setting.

The ketamine safe dose range provides a strong foundation. But the real work of safety happens in how we prepare patients, how we stay present with them, and how we help them integrate what they’ve learned.

At Lumin Health, we believe that safety is not the absence of risk — it’s the presence of trust. And in the right hands, ketamine therapy can be not only safe, but profoundly transformative. We greatly encourage you to reach out to our team directly to discuss any specific concerns, as each individual case is complex and requires careful consideration. 

References

1. Wan LB, Levitch CF, Perez AM, et al. Ketamine safety and tolerability in clinical trials for treatment-resistant depression. J Clin Psychiatry. 2015;76(3):247-52. PubMed
2. Short B, Fong J, Galvez V, et al. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2018;5(1):65-78. PubMed
3. Vekhova KA, Namiot ED, Jonsson J, et al. Ketamine and Esketamine in Clinical Trials: FDA-Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations. Clin Pharmacol Ther. 2025;117(2):374-386. PubMed
4. Riva-Posse P, Reiff CM, Edwards JA, et al. Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions. J Affect Disord. 2018;236:291-297. PubMed
5. Le TT, Cordero IP, Jawad MY, et al. The abuse liability of ketamine: A scoping review of preclinical and clinical studies. J Psychiatr Res. 2022;151:476-496. PubMed
6. Green SM, Roback MG, Kennedy RM, et al. Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 update. Ann Emerg Med. 2011;57(5):449-61. PubMed

You've read the science. Now take the next step.

Lumin Health provides safe, expert-administered ketamine and Spravato treatment across Massachusetts and the greater Washington DC/Maryland area. Your journey starts with a free, no-commitment intro call.

Available in Massachusetts and the greater Washington DC/Maryland area.

Book a Free Intro Call

Frequently Asked Questions

Is ketamine therapy safe?

Yes, when it's given in a supervised clinical setting with proper screening and monitoring. Dosing for mental health is much lower than an anesthetic dose, and providers rule out cardiovascular and psychiatric contraindications before treatment starts. Ketamine has a decades-long safety record, and most side effects, like mild nausea, dizziness, or temporary dissociation, resolve quickly with support.

What are the potential risks or side effects of ketamine therapy?

The most common effects are a temporary rise in heart rate or blood pressure, along with dissociation, perceptual changes, or a dreamlike feeling during dosing. These effects are expected, closely monitored, and typically pass within hours. Ketamine does carry some risk of misuse in unsupervised settings, but structured use with measured dosing and clinical oversight carries a low risk of dependence.

How is a safe dose of ketamine determined?

Dosing for depression and other mental health conditions is much lower than an anesthetic dose and is based on your body weight, medical history, and how you've responded before. Your care team typically starts at the low end and adjusts from there based on how you respond. Esketamine (Spravato) is given in fixed, FDA-guided doses through its nasal spray form.

What screening happens before starting ketamine or esketamine therapy?

Before treatment begins, your care team screens for physical and psychiatric contraindications and reviews your medical history and any previous responses to treatment. You're then monitored by licensed clinicians throughout each session, with recovery monitoring for a period of time afterward. This screening and monitoring is part of what keeps ketamine and esketamine treatment safe.